Resultados: 2

Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted

England. National Institute for Health and Care Excellence.

Evidence-based recommendations on nintedanib (Ofev) for treating idiopathic pulmonary fibrosis in adults when forced vital capacity is above 80% predicted. This technology appraisal is for treating idiopathic pulmonary fibrosis in people with a forced vital capacity (FVC) above 80% predicted. Nintedanib...

Fibrose Pulmonar Idiopática/terapia, Antifibróticos/uso terapêutico, Capacidade Vital

Texto completo

Idiopathic pulmonary fibrosis in adults: diagnosis and management

England. National Institute for Health and Care Excellence.

This guideline covers diagnosing and managing idiopathic pulmonary fibrosis in people aged 18 and over. It aims to improve the quality of life for people with idiopathic pulmonary fibrosis by helping healthcare professionals to diagnose the condition and provide effective symptom management. NICE has pro...

Fibrose Pulmonar Idiopática/diagnóstico, Fibrose Pulmonar Idiopática/tratamento farmacológico, Fibrose Pulmonar Idiopática/terapia, Cuidados Paliativos, Antimetabólitos/uso terapêutico, Transplante de Pulmão

Texto completo